While It Is Well Established That Long Term Good Glycaemic Control Will Reduce The Risk Of Diabetic Retinopathy Development And Progression Intensification Of Glycaemic Control Has Also Been Associated With An Initial Worsening Of Diabetic Retinopathy This Phenomenon Is Known As Early Worsening The Rationale Of This Trial Is To Establish The Long Term Effects Of Semaglutide On Diabetic Retinopathy In Subjects With Type 2 Diabetes T2d Using Validated And Standardised Ophthalmic Assessments This Trial Is A Post Authorisation Safety Study Pass Conducted As A Commitment To The European Medicines Agency clinical trials

Explore recruiting while it is well established that long term good glycaemic control will reduce the risk of diabetic retinopathy development and progression intensification of glycaemic control has also been associated with an initial worsening of diabetic retinopathy this phenomenon is known as early worsening the rationale of this trial is to establish the long term effects of semaglutide on diabetic retinopathy in subjects with type 2 diabetes t2d using validated and standardised ophthalmic assessments this trial is a post authorisation safety study pass conducted as a commitment to the european medicines agency clinical trials.

Also recruiting in Europe

While It Is Well Established That Long Term Good Glycaemic Control Will Reduce The Risk Of Diabetic Retinopathy Development And Progression Intensification Of Glycaemic Control Has Also Been Associated With An Initial Worsening Of Diabetic Retinopathy This Phenomenon Is Known As Early Worsening The Rationale Of This Trial Is To Establish The Long Term Effects Of Semaglutide On Diabetic Retinopathy In Subjects With Type 2 Diabetes T2d Using Validated And Standardised Ophthalmic Assessments This Trial Is A Post Authorisation Safety Study Pass Conducted As A Commitment To The European Medicines Agency trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Long-term effects of semaglutide on diabetic retinopathy in subjects with type 2 diabetes (FOCUS)

Portugal, Poland, Spain, Romania, Czechia, Germany +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

While It Is Well Established That Long Term Good Glycaemic Control Will Reduce The Risk Of Diabetic Retinopathy Development And Progression Intensification Of Glycaemic Control Has Also Been Associated With An Initial Worsening Of Diabetic Retinopathy This Phenomenon Is Known As Early Worsening The Rationale Of This Trial Is To Establish The Long Term Effects Of Semaglutide On Diabetic Retinopathy In Subjects With Type 2 Diabetes T2d Using Validated And Standardised Ophthalmic Assessments This Trial Is A Post Authorisation Safety Study Pass Conducted As A Commitment To The European Medicines Agency trials by city

While It Is Well Established That Long Term Good Glycaemic Control Will Reduce The Risk Of Diabetic Retinopathy Development And Progression Intensification Of Glycaemic Control Has Also Been Associated With An Initial Worsening Of Diabetic Retinopathy This Phenomenon Is Known As Early Worsening The Rationale Of This Trial Is To Establish The Long Term Effects Of Semaglutide On Diabetic Retinopathy In Subjects With Type 2 Diabetes T2d Using Validated And Standardised Ophthalmic Assessments This Trial Is A Post Authorisation Safety Study Pass Conducted As A Commitment To The European Medicines Agency in Toronto While It Is Well Established That Long Term Good Glycaemic Control Will Reduce The Risk Of Diabetic Retinopathy Development And Progression Intensification Of Glycaemic Control Has Also Been Associated With An Initial Worsening Of Diabetic Retinopathy This Phenomenon Is Known As Early Worsening The Rationale Of This Trial Is To Establish The Long Term Effects Of Semaglutide On Diabetic Retinopathy In Subjects With Type 2 Diabetes T2d Using Validated And Standardised Ophthalmic Assessments This Trial Is A Post Authorisation Safety Study Pass Conducted As A Commitment To The European Medicines Agency in Vancouver While It Is Well Established That Long Term Good Glycaemic Control Will Reduce The Risk Of Diabetic Retinopathy Development And Progression Intensification Of Glycaemic Control Has Also Been Associated With An Initial Worsening Of Diabetic Retinopathy This Phenomenon Is Known As Early Worsening The Rationale Of This Trial Is To Establish The Long Term Effects Of Semaglutide On Diabetic Retinopathy In Subjects With Type 2 Diabetes T2d Using Validated And Standardised Ophthalmic Assessments This Trial Is A Post Authorisation Safety Study Pass Conducted As A Commitment To The European Medicines Agency in Montreal While It Is Well Established That Long Term Good Glycaemic Control Will Reduce The Risk Of Diabetic Retinopathy Development And Progression Intensification Of Glycaemic Control Has Also Been Associated With An Initial Worsening Of Diabetic Retinopathy This Phenomenon Is Known As Early Worsening The Rationale Of This Trial Is To Establish The Long Term Effects Of Semaglutide On Diabetic Retinopathy In Subjects With Type 2 Diabetes T2d Using Validated And Standardised Ophthalmic Assessments This Trial Is A Post Authorisation Safety Study Pass Conducted As A Commitment To The European Medicines Agency in Calgary While It Is Well Established That Long Term Good Glycaemic Control Will Reduce The Risk Of Diabetic Retinopathy Development And Progression Intensification Of Glycaemic Control Has Also Been Associated With An Initial Worsening Of Diabetic Retinopathy This Phenomenon Is Known As Early Worsening The Rationale Of This Trial Is To Establish The Long Term Effects Of Semaglutide On Diabetic Retinopathy In Subjects With Type 2 Diabetes T2d Using Validated And Standardised Ophthalmic Assessments This Trial Is A Post Authorisation Safety Study Pass Conducted As A Commitment To The European Medicines Agency in Edmonton While It Is Well Established That Long Term Good Glycaemic Control Will Reduce The Risk Of Diabetic Retinopathy Development And Progression Intensification Of Glycaemic Control Has Also Been Associated With An Initial Worsening Of Diabetic Retinopathy This Phenomenon Is Known As Early Worsening The Rationale Of This Trial Is To Establish The Long Term Effects Of Semaglutide On Diabetic Retinopathy In Subjects With Type 2 Diabetes T2d Using Validated And Standardised Ophthalmic Assessments This Trial Is A Post Authorisation Safety Study Pass Conducted As A Commitment To The European Medicines Agency in Ottawa While It Is Well Established That Long Term Good Glycaemic Control Will Reduce The Risk Of Diabetic Retinopathy Development And Progression Intensification Of Glycaemic Control Has Also Been Associated With An Initial Worsening Of Diabetic Retinopathy This Phenomenon Is Known As Early Worsening The Rationale Of This Trial Is To Establish The Long Term Effects Of Semaglutide On Diabetic Retinopathy In Subjects With Type 2 Diabetes T2d Using Validated And Standardised Ophthalmic Assessments This Trial Is A Post Authorisation Safety Study Pass Conducted As A Commitment To The European Medicines Agency in Winnipeg While It Is Well Established That Long Term Good Glycaemic Control Will Reduce The Risk Of Diabetic Retinopathy Development And Progression Intensification Of Glycaemic Control Has Also Been Associated With An Initial Worsening Of Diabetic Retinopathy This Phenomenon Is Known As Early Worsening The Rationale Of This Trial Is To Establish The Long Term Effects Of Semaglutide On Diabetic Retinopathy In Subjects With Type 2 Diabetes T2d Using Validated And Standardised Ophthalmic Assessments This Trial Is A Post Authorisation Safety Study Pass Conducted As A Commitment To The European Medicines Agency in Quebec City While It Is Well Established That Long Term Good Glycaemic Control Will Reduce The Risk Of Diabetic Retinopathy Development And Progression Intensification Of Glycaemic Control Has Also Been Associated With An Initial Worsening Of Diabetic Retinopathy This Phenomenon Is Known As Early Worsening The Rationale Of This Trial Is To Establish The Long Term Effects Of Semaglutide On Diabetic Retinopathy In Subjects With Type 2 Diabetes T2d Using Validated And Standardised Ophthalmic Assessments This Trial Is A Post Authorisation Safety Study Pass Conducted As A Commitment To The European Medicines Agency in Hamilton While It Is Well Established That Long Term Good Glycaemic Control Will Reduce The Risk Of Diabetic Retinopathy Development And Progression Intensification Of Glycaemic Control Has Also Been Associated With An Initial Worsening Of Diabetic Retinopathy This Phenomenon Is Known As Early Worsening The Rationale Of This Trial Is To Establish The Long Term Effects Of Semaglutide On Diabetic Retinopathy In Subjects With Type 2 Diabetes T2d Using Validated And Standardised Ophthalmic Assessments This Trial Is A Post Authorisation Safety Study Pass Conducted As A Commitment To The European Medicines Agency in Kitchener While It Is Well Established That Long Term Good Glycaemic Control Will Reduce The Risk Of Diabetic Retinopathy Development And Progression Intensification Of Glycaemic Control Has Also Been Associated With An Initial Worsening Of Diabetic Retinopathy This Phenomenon Is Known As Early Worsening The Rationale Of This Trial Is To Establish The Long Term Effects Of Semaglutide On Diabetic Retinopathy In Subjects With Type 2 Diabetes T2d Using Validated And Standardised Ophthalmic Assessments This Trial Is A Post Authorisation Safety Study Pass Conducted As A Commitment To The European Medicines Agency in London While It Is Well Established That Long Term Good Glycaemic Control Will Reduce The Risk Of Diabetic Retinopathy Development And Progression Intensification Of Glycaemic Control Has Also Been Associated With An Initial Worsening Of Diabetic Retinopathy This Phenomenon Is Known As Early Worsening The Rationale Of This Trial Is To Establish The Long Term Effects Of Semaglutide On Diabetic Retinopathy In Subjects With Type 2 Diabetes T2d Using Validated And Standardised Ophthalmic Assessments This Trial Is A Post Authorisation Safety Study Pass Conducted As A Commitment To The European Medicines Agency in Halifax While It Is Well Established That Long Term Good Glycaemic Control Will Reduce The Risk Of Diabetic Retinopathy Development And Progression Intensification Of Glycaemic Control Has Also Been Associated With An Initial Worsening Of Diabetic Retinopathy This Phenomenon Is Known As Early Worsening The Rationale Of This Trial Is To Establish The Long Term Effects Of Semaglutide On Diabetic Retinopathy In Subjects With Type 2 Diabetes T2d Using Validated And Standardised Ophthalmic Assessments This Trial Is A Post Authorisation Safety Study Pass Conducted As A Commitment To The European Medicines Agency in New York While It Is Well Established That Long Term Good Glycaemic Control Will Reduce The Risk Of Diabetic Retinopathy Development And Progression Intensification Of Glycaemic Control Has Also Been Associated With An Initial Worsening Of Diabetic Retinopathy This Phenomenon Is Known As Early Worsening The Rationale Of This Trial Is To Establish The Long Term Effects Of Semaglutide On Diabetic Retinopathy In Subjects With Type 2 Diabetes T2d Using Validated And Standardised Ophthalmic Assessments This Trial Is A Post Authorisation Safety Study Pass Conducted As A Commitment To The European Medicines Agency in Los Angeles While It Is Well Established That Long Term Good Glycaemic Control Will Reduce The Risk Of Diabetic Retinopathy Development And Progression Intensification Of Glycaemic Control Has Also Been Associated With An Initial Worsening Of Diabetic Retinopathy This Phenomenon Is Known As Early Worsening The Rationale Of This Trial Is To Establish The Long Term Effects Of Semaglutide On Diabetic Retinopathy In Subjects With Type 2 Diabetes T2d Using Validated And Standardised Ophthalmic Assessments This Trial Is A Post Authorisation Safety Study Pass Conducted As A Commitment To The European Medicines Agency in Chicago While It Is Well Established That Long Term Good Glycaemic Control Will Reduce The Risk Of Diabetic Retinopathy Development And Progression Intensification Of Glycaemic Control Has Also Been Associated With An Initial Worsening Of Diabetic Retinopathy This Phenomenon Is Known As Early Worsening The Rationale Of This Trial Is To Establish The Long Term Effects Of Semaglutide On Diabetic Retinopathy In Subjects With Type 2 Diabetes T2d Using Validated And Standardised Ophthalmic Assessments This Trial Is A Post Authorisation Safety Study Pass Conducted As A Commitment To The European Medicines Agency in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease